Patents for C12N 15 - Mutation or genetic engineering; Dna or rna concerning genetic engineering, vectors, e.g. plasmids, or their isolation, preparation or purification; Use of hosts therefor (402,210) |
---|
06/28/2001 | CA2394741A1 Inducing cellular immune responses to prostate cancer antigens using peptide and nucleic acid compositions |
06/28/2001 | CA2394728A1 Production of transgenic plants of the tagetes species |
06/28/2001 | CA2394652A1 Probes and primers for the detection of polyphosphate accumulating organisms in wastewater |
06/28/2001 | CA2394618A1 Method for isolation of rna from formalin-fixed paraffin-embedded tissue specimens |
06/28/2001 | CA2394614A1 Embryonic or stem-like cells produced by cross species nuclear transplantation |
06/28/2001 | CA2394049A1 Vesicle trafficking proteins |
06/28/2001 | CA2394015A1 Tweak receptor |
06/28/2001 | CA2393855A1 Homologues of human heparanase and splice variants thereof |
06/28/2001 | CA2393849A1 System and method for automated matched ion polynucleotide chromatography |
06/28/2001 | CA2393646A1 Survivin promotion of angiogenesis |
06/28/2001 | CA2393500A1 Methods and compositions for detecting hepatitis e virus |
06/28/2001 | CA2392827A1 Double selection vector |
06/28/2001 | CA2392787A1 Nk cell receptor polynucleotides, polypeptides, and antibodies |
06/28/2001 | CA2392150A1 Diamidine compounds as dna minor groove binders |
06/28/2001 | CA2391594A1 Trefoil domain-containing polynucleotides, polypeptides, and antibodies |
06/28/2001 | CA2391374A1 Il-17 homologous polypeptides and therapeutic uses thereof |
06/28/2001 | CA2391314A1 Multispecies food testing and characterization |
06/28/2001 | CA2390691A1 Methods and compositions for prolonging elimination half-times of bioactive compounds |
06/28/2001 | CA2327533A1 A method for typing polymorphisms of bovine mhc class ii genes |
06/27/2001 | EP1111068A1 Branched compound for use in nucleic acid detection and analysis reactions |
06/27/2001 | EP1111063A1 Modified DHPS genes |
06/27/2001 | EP1111062A1 Nucleotide sequences encoding the gene zwa1 |
06/27/2001 | EP1111061A1 Double selection vector |
06/27/2001 | EP1111060A1 A novel human lysozyme gene, its encoding polypeptide and the method for preparing them |
06/27/2001 | EP1111059A1 A novel human lysozyme gene, its encoding polypeptide and the method preparing for them |
06/27/2001 | EP1111058A1 A novel human lysozyme gene, its encoding polypeptide and the method for preparing them |
06/27/2001 | EP1111057A1 Prodrug ribozyme |
06/27/2001 | EP1111056A2 Process for activating a kinase |
06/27/2001 | EP1111055A1 Plant enzymes with phospholipid hydroperoxide glutathione peroxidase activity, their analogues and their use |
06/27/2001 | EP1111054A1 A new gene of human lysoenzyme, the encoding polypeptide and methods for preparing them |
06/27/2001 | EP1111053A2 Peptide fragment of the respiratory syncytial virus G protein, immunogenic agent, pharmaceutical composition containing same, and preparation method |
06/27/2001 | EP1111052A1 Novel gene |
06/27/2001 | EP1111051A1 Promoter for guard cell-specific gene expression in plants |
06/27/2001 | EP1111050A2 Human procalcitonin, its production and use |
06/27/2001 | EP1111049A1 Novel receptor protein and method for diagnosing inflammatory diseases by using the same |
06/27/2001 | EP1111048A2 Neutral amino acid transporter and gene thereof |
06/27/2001 | EP1111047A2 Novel protein and dna thereof |
06/27/2001 | EP1111046A1 Novel protein and process for producing the same |
06/27/2001 | EP1111045A2 Apoptin-associating protein |
06/27/2001 | EP1111044A1 Method for synthesizing dna |
06/27/2001 | EP1111043A1 New QTL's on chromosomes X, 2, 6 and 7 of pigs |
06/27/2001 | EP1111042A1 Antibodies for judging possibility of the onset of bovine leukemia |
06/27/2001 | EP1110970A1 Anti-Procalcitonin antibody, their production and use |
06/27/2001 | EP1110969A1 Interleukin 18-binding protein |
06/27/2001 | EP1110090A1 Multihued labels |
06/27/2001 | EP1110089A1 Chemiluminescent immunoassay for detection of antibodies to various viruses |
06/27/2001 | EP1110088A1 Energy transfer dyes |
06/27/2001 | EP1110086A1 Production of motif-specific and context-independent antibodies using peptide libraries as antigens |
06/27/2001 | EP1109937A1 A novel method of diagnosing, monitoring, staging, imaging and treating various cancers |
06/27/2001 | EP1109935A2 Two-colour differential display, used as a method for detecting regulated genes |
06/27/2001 | EP1109932A1 Methods for detecting and measuring spliced nucleic acids |
06/27/2001 | EP1109931A1 METHOD FOR STUDYING PROTEIN INTERACTIONS $i(IN VIVO) |
06/27/2001 | EP1109928A1 Enzymatic oxidative deamination process |
06/27/2001 | EP1109926A1 Condensed plasmid-liposome complex for transfection |
06/27/2001 | EP1109925A1 Recombinant adenovirus for tissue specific expression in heart |
06/27/2001 | EP1109924A2 Methylation of plasmid vectors |
06/27/2001 | EP1109923A1 Modification of plant development and plant cell differentiation by use of the deac system |
06/27/2001 | EP1109922A1 Method for the production of heterologous polypeptides in transformed yeast cells |
06/27/2001 | EP1109921A1 Fusion receptors specific for prostate-specific membrane antigen and uses thereof |
06/27/2001 | EP1109920A1 Fusion proteins, dna molecules, vectors, and host cells useful for measuring protease activity |
06/27/2001 | EP1109919A2 Rationally designed heparinases derived from heparinase i and ii |
06/27/2001 | EP1109918A2 Polypeptides, polynucleotides and uses thereof |
06/27/2001 | EP1109917A2 Human transferase proteins |
06/27/2001 | EP1109916A1 Nucleic acid molecules encoding an amylosucrase |
06/27/2001 | EP1109915A1 Nucleotide sequences for the tal gene |
06/27/2001 | EP1109913A1 Nucleotide sequences which code for the opca gene |
06/27/2001 | EP1109912A1 Phenolic acid esterases, coding sequences and methods |
06/27/2001 | EP1109911A2 Staphylococcus aureus genes and polypeptides |
06/27/2001 | EP1109910A2 Thioredoxin h homologs |
06/27/2001 | EP1109909A2 Grf analogs with increased biological potency |
06/27/2001 | EP1109908A2 Leptin induced genes |
06/27/2001 | EP1109907A1 Human cell junction pdz protein |
06/27/2001 | EP1109906A1 Methods and compositions for modulating the interaction between the apj receptor and the hiv virus |
06/27/2001 | EP1109905A1 Genes encoding for the human and murine death inducer-obliterator-1 |
06/27/2001 | EP1109904A1 Novel molecules of the herpes virus-entry-mediator-related protein family and uses thereof |
06/27/2001 | EP1109903A2 Human rna-associated proteins |
06/27/2001 | EP1109902A1 Voltage-gated calcium channel |
06/27/2001 | EP1109901A2 GABA B RECEPTOR SUBTYPES GABA B-R1c AND GABA B-R2 AND HETERODIMERS THEREOF |
06/27/2001 | EP1109900A1 Angiocidin: a cys-ser-val-thr-cys-gly specific tumor cell adhesion receptor |
06/27/2001 | EP1109899A1 Product and method for separation of a sample containing multiple sources of genetic material using a solid medium |
06/27/2001 | EP1109898A1 Method for selecting peptides inhibiting viral surface protein binding to cell surface receptor |
06/27/2001 | EP1109897A1 Method for selecting peptides for the targeted transport of drugs and markers, and peptides discovered using said method |
06/27/2001 | EP1109896A1 Adenovirus formulations for gene therapy |
06/27/2001 | EP1109895A1 Endothelial cell proliferation inhibitors derived from human prothrombin |
06/27/2001 | EP1109894A1 Recombinant vanadium haloperoxidases and their uses |
06/27/2001 | EP1109893A2 Papillomaviruses, means for the detection thereof and therapy for diseases caused thereby |
06/27/2001 | EP1109892A2 Methods for generating high titer helper-free preparations of released recombinant aav vectors |
06/27/2001 | EP1109891A1 Method for producing cloned cows |
06/27/2001 | EP1109890A1 Method for producing human cloned embryos by employing inter-species nuclear transplantation technique |
06/27/2001 | EP1109889A1 Transformation, selection, and screening of sequence-shuffled polynucleotides for development and optimization of plant phenotypes |
06/27/2001 | EP1109886A1 Process for preparing clavam derivatives by using polypeptides having beta-lactam synthetase activity |
06/27/2001 | EP1109833A2 Compositions and methods for the treatment of tumors |
06/27/2001 | EP1109830A1 Mc4-r as target for the identification of compounds used to treat drug addiction |
06/27/2001 | EP1109829A1 Human latent transforming growth factor beta binding protein 3 |
06/27/2001 | EP1109824A1 Novel bag proteins and nucleic acid molecules encoding them |
06/27/2001 | EP1109823A1 Modifications of the vegf receptor-2 protein and methods of use |
06/27/2001 | EP1109822A1 Factor 8 homologue nucleic acids, polypeptides, methods, uses |
06/27/2001 | EP1109821A1 49 human secreted proteins |
06/27/2001 | EP1109624A1 Capillary printing systems |
06/27/2001 | EP1109582A1 Methods to enhance and confine expression of genes |